SX reduces oxidative stress in nonalcoholic steatohepatitis, suggesting therapeutic value for NASH management.
SX ameliorates HFHC diet-induced NASH by regulating hepatic oxidative stress and AMPK pathway, suggesting the potential therapeutic value of SX in NASH treatment.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: